Physician profile
David Christopher Lobb
NPI 1386084226
$2,293.78
in general payments reported to CMS, 2019-2025
10 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Plastic Surgery Within The Head and Neck provider received nationally (typical 2025 total: $300).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $152 · 2023: $870 · 2024: $778 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692 · Travel and Lodging: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.55 |
| Travel and Lodging | $230.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $747.12 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Kls-Martin L.P. | $735.32 | 2021-2023 | |
| Musculoskeletal Transplant Foundation INC. | $200.95 | 2024 | |
| Depuy Synthes Sales INC. | $182.52 | 2023-2024 | Trumatch, Na |
| Integra Lifesciences Corporation | $182.45 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Abbvie INC. | $110.32 | 2023-2024 | |
| Acera Surgical, INC. | $52.90 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $49.71 | 2021-2024 | Collagenase Santyl |
| Access Pro Medical, LLC | $20.11 | 2023 | Matriderm |
| Sientra, INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.